Navigation Links
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Date:5/13/2009

First and only oral antidiabetic fixed-dose combination medication approved with the extended-release form of metformin

DEERFIELD, Ill. and OSAKA, Japan, May 13 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved an extended-release version of the combination medication ACTOplus met(R) (pioglitazone HCl and metformin HCl) as an adjunct to diet and exercise for the treatment of type 2 diabetes. ACTOplus met(R) XR is the first and only prescription oral antidiabetic fixed-dose combination medication available with the extended-release form of metformin to help improve glycemic control in a convenient, once-daily dosing option. ACTOplus met XR is indicated for adults with type 2 diabetes who are already treated with ACTOS(R) (pioglitazone HCl) and metformin or who have inadequate glycemic control on ACTOS or metformin alone.

ACTOplus met XR combines ACTOS and metformin, two widely used medications in a single tablet. ACTOS directly targets insulin resistance, a condition in which the body does not efficiently use the insulin it produces. Metformin acts by reducing the amount of glucose produced by the liver. These medications work in combination to help patients with type 2 diabetes manage their blood glucose levels.

Extended-release metformin, one of the active ingredients in ACTOplus met XR, was developed by Watson Laboratories, a subsidiary of Watson Pharmaceuticals, Inc. and licensed to Takeda Pharmaceutical Company Limited. Takeda expects ACTOplus met XR to be available later this calendar year.

About Type 2 Diabetes

Diabetes has reached epidemic proportions in the United States. Almost 24 million people currently live with diabetes and, of these, 5.7 million are unaware that
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
2. FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
3. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
4. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
5. FDA Approves Plan B Pill for 17-Year-Olds
6. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
7. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
8. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
9. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
10. FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
11. FDA Approves Two Hologic HPV Tests

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Caregiving: Ready or Not helps families prepare f... Cincinnati, Ohio (PRWEB) December 2,...ssion to help families understand and embrace the ... hope our loved ones live long, healthy and prospe...e care at some point, and their needs often become...
(Date:12/1/2009)... Free hearing aids will be given by Estes Audiolog... Austin, TX (PRWEB) December 1, 2...a professional hearing healthcare provider dedicat...and their families, announced today the beginning ...way. Each year, Estes Audiology donates two pairs...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Stemedic...) Board of Directors at the Company’s Novemb...(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD ...Inc. (“Stemedica”) Board of Directors .... Roger J. Howe, PhD, Executive Chairman for Steme...
(Date:12/1/2009)...CH, Calif., Dec. 1 To date, hospit...ll reimburse them for the $20 cost of the disposab... for surgery. ,, Anesthesiologists have not tol...void postop dementia from routine anesthesia over-... the ,avoid over-medication, message from their le...
(Date:12/1/2009)... Dec. 1 Cell Therapeut...s presentation at the 21st Annual Piper Jaffray He...00 a.m. Eastern Time will be webcast live at www....ll take place in Holmes 1 at the New York Palace H...the presentation. , , Piper ...
Breaking Medicine News(10 mins):Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2
...ish Medical Journal has suggested that pharmaceuti... sexual disorders and are defining the condition i... Drug companies are trying to recreate// the ki...ers are being unduly medicalised and the coining o...
... cancer cannot be prolonged by psychological inter... Does mind play a role in cancer? Yes. People wit.../ at the time of diagnosis to help them cope with ...ranteed for sure. A team at Peninsula Medical...
...teenagers heading back to school is the attack of ...ern Medical Center say that stress is one of the m...ress produces increased secretion of the hormone a... are already underway. Pimples occur when excess o...
...n found by researchers to be more effective than p...h borderline personality disorder. This study , wh...en with borderline// personality disorder between ...impulsivity and aggression when given fluvoxamine ...
...researchers have observed that there is evidence w...the best way forward in peripheral arterial diseas... will be affected by peripheral arterial disease (...ould think walking would be the worst thing you co...
...otein in the eye has prevented and stopped autoimm...s say this could lead to promising treatments for ...osis and type 1 diabetes. Scientists from the...nset of and stop the progression of uveitis in mic...
Other Medicine News:
(Date:11/30/2009)...VINA, Calif., Nov. 30 StemCyte, In...ation agreement with Academia Sinica, the National...hods and Intellectual Property (IP) related to the...s method and IP was pioneered by a team led by Pro...inica. Professor Lin is currently the exclusive c...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.c...available in its catalogue: ,, Inflammatory Di...mune Response ,, http://www.reportlinker.com/...press-or-Balance-the-Immune-Response.html ,, T...ng an individual body or producing an exaggerated ...
(Date:11/30/2009)...ALTON, Ill., Nov. 30 The Simmons l...dedicated to representing thousands of women that ...the popular birth control pill manufactured and ma...dicial Panel on Multidistrict Litigation has order...ill lawsuits be consolidated and centralized for p...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 1Drugs for Inflammatory Bowel Might Increase Cancer Risk 59751 2Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 1Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 2Majesco Entertainment and Interactive Game Group Release Jillian Michaels Fitness Ultimatum 2010 For Nintendo DS 28TM 29 59747 3IPRO Wins Federal Contract to Support Hospice Oversight 59743 1IPRO Wins Federal Contract to Support Hospice Oversight 59743 2
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: